Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cascara sagrada, aloe rule

This article was originally published in The Tan Sheet

Executive Summary

OTC laxative drug products containing cascara sagrada or aloe that were in interstate commerce as of Nov. 5 can be sold until stock is depleted, FDA says. However, such drugs cannot be introduced into interstate commerce after that date, when FDA's final rule classifying the ingredients as Category II in OTC laxatives took effect. Agency is completing responses to petitions by AHPA and others requesting stay of rule's effective date and enforcement action. Reg does not cover dietary supplements containing the ingredients, FDA notes...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS094753

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel